Bracco forms Chinese joint venture

Contrast agent developer Bracco Group has formed a joint venture with Sine Pharmaceutical of Shanghai for the production and marketing of diagnostic imaging contrast media in China.

The new Bracco-Sine joint venture, which will be owned 70% by Bracco, will launch a MRI as well as a second-generation ultrasound contrast agent in China later this month, according to Milan-based Bracco.

By staff writers
April 5, 2004

Related Reading

Bracco adds Christus Health, April 5, 2004

Eastern Isotopes, Bracco team up, June 24, 2003

Bracco opens new research center, March 28, 2003

Bracco issues Isovue clarification, March 17, 2003

Bracco set to reintroduce Kinevac, December 6, 2002

Copyright © 2004

Page 1 of 3593
Next Page